SCHEMBL6918525

SCHEMBL6918525

[C]Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 1/20 0.55
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CES1 P23141 2/20 0.53
CA9 Q16790 1/20 0.53
CES2 O00748 1/20 0.53
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 2/20 0.50
ACHE P22303 2/20 0.50
LMNA P02545 2/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11689190 0.80 HSPB1 (0.79) HSPB1CA1CA2CES1CA9
4,4'-Oxybis(Nitrobenzene) SCHEMBL134332 0.80 HSPB1 (0.79) HSPB1CA1CA2CES1CA9
SCHEMBL9183872 0.80 HSPB1 (0.79) HSPB1CA1CA2CES1CA9
SCHEMBL2011179 0.80 HSPB1 (0.79) HSPB1CA1CA2CES1CA9
SCHEMBL27909482 0.79 ALDH1A1 (0.72) CA1CA2CES1CA9ALDH1A1
SCHEMBL22567 0.79 ALDH1A1 (0.72) CA1CA2CES1CA9ALDH1A1
4,4'-Oxybis(Nitrobenzene) SCHEMBL8934595 0.78 HSPB1 (0.76) HSPB1CA1CA2CES1CA9
SCHEMBL4016593 0.76 HSPB1 (0.55) HSPB1CA1CA2CES1CA9
SCHEMBL492221 0.76 APP (0.70) HSPB1ALDH1A1HSD17B10ACHELMNA
SCHEMBL5608830 0.76 HSPB1 (0.55) HSPB1CA1CA2CES1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0981542-B1 20(S) CAMPTOTHECIN GLYCOCONJUGATES BAYER HEALTHCARE AG (DE) 2004-08-04 EP disclosed
WO-1998000121-A1 ANTICANCER AGENTS MILLENNIUM PHARMACEUTICALS, INC. (US) 1998-01-08 WO disclosed